UA111587C2 - COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO AMYLOID OR AMYLOID PROTEINS - Google Patents

COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO AMYLOID OR AMYLOID PROTEINS

Info

Publication number
UA111587C2
UA111587C2 UAA201213038A UAA201213038A UA111587C2 UA 111587 C2 UA111587 C2 UA 111587C2 UA A201213038 A UAA201213038 A UA A201213038A UA A201213038 A UAA201213038 A UA A201213038A UA 111587 C2 UA111587 C2 UA 111587C2
Authority
UA
Ukraine
Prior art keywords
amyloid
compounds
treatment
proteins
diseases
Prior art date
Application number
UAA201213038A
Other languages
Ukrainian (uk)
Inventor
Хайко Крот
Котініка Хамел
Паскаль Бендеріттер
Вольфганг ФРЕСТЛЬ
Нампаллі Среєнівасачарі
Андреас МУС
Original Assignee
Ац Іммуне С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ац Іммуне С.А. filed Critical Ац Іммуне С.А.
Priority claimed from PCT/EP2011/056068 external-priority patent/WO2011128455A1/en
Publication of UA111587C2 publication Critical patent/UA111587C2/en

Links

Abstract

Даний винахід стосується нових сполук, які можуть застосовуватися при лікуванні групи розладів і порушень, пов'язаних з амілоїдним білком, таких як хвороба Альцгеймера, і захворювань або станів, пов'язаних з амілоїдоподібними білками. Сполуки даного винаходу можуть також застосовуватися при лікуванні очних захворювань, пов'язаних з патологічними порушеннями/змінами в тканині візуальної системи. Крім того, даний винахід стосується фармацевтичних композицій, що включають ці сполуки, і застосування цих сполук для отримання лікарських препаратів для лікування або запобігання захворюванням або станам, пов'язаних з амілоїдними і/або амілоїдоподібними білками. Крім того, розкривається спосіб лікування або запобігання захворюванням або станам, пов'язаним з амілоїдними і/або амілоїдоподібними білками.The present invention relates to novel compounds that can be used in the treatment of a group of disorders and disorders associated with amyloid protein, such as Alzheimer's disease, and diseases or conditions associated with amyloid proteins. The compounds of this invention can also be used in the treatment of eye diseases associated with pathological disorders / changes in the tissue of the visual system. In addition, the present invention relates to pharmaceutical compositions comprising these compounds and the use of these compounds for the preparation of medicaments for the treatment or prevention of diseases or conditions associated with amyloid and / or amyloid proteins. In addition, there is disclosed a method of treating or preventing a disease or condition associated with amyloid and / or amyloid proteins.

UAA201213038A 2010-04-16 2011-04-15 COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO AMYLOID OR AMYLOID PROTEINS UA111587C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10160223 2010-04-16
PCT/EP2011/056068 WO2011128455A1 (en) 2010-04-16 2011-04-15 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins

Publications (1)

Publication Number Publication Date
UA111587C2 true UA111587C2 (en) 2016-05-25

Family

ID=56291998

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201213038A UA111587C2 (en) 2010-04-16 2011-04-15 COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO AMYLOID OR AMYLOID PROTEINS

Country Status (1)

Country Link
UA (1) UA111587C2 (en)

Similar Documents

Publication Publication Date Title
MY173699A (en) Novel compounds for the treatment of diseases associated with amyloid of amyloid-like proteins
MX2009005279A (en) N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's.
BR112014008789A2 (en) prevention and treatment of eye conditions
MY171300A (en) Pharmaceutical composition
EA201590655A1 (en) COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
WO2012080729A3 (en) Casein kinase 1delta (ck1delta) inhibitors and their use in the treatment of neurodegenerative diseases such as tauopathies
EA201270824A1 (en) COMPOUNDS TO REDUCE BET-AMYLOID PRODUCTS
BR112015014458A2 (en) mannose derivatives for the treatment of bacterial infections
EA201590654A1 (en) COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE
EA201300471A1 (en) SUBSTITUTED 6-AMINONICOTINAMIDES AS KCNQ2 / 3 MODULATORS
ME02414B (en) Treatment of crohn's disease with laquinimod
EA201790653A1 (en) METHOD OF TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS
NZ589807A (en) Method for preventing and treating neurodegenerative diseases using a grape seed extract having less than 12% by weight galloylated proanthocyanidins
PH12017500444A1 (en) Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia
EA201491606A1 (en) KINURENIN-3-MONOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR USE
MX355770B (en) Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use.
EA201590687A1 (en) TREATMENT OF LUNG AND MODERN DISEASE OF ALZHEIMER
BR112014029597A2 (en) chroman compounds
EA201591021A1 (en) 4-HYDROXY-2-METHIL-5- (PROPAN-2-ILIDEN) CYCLOGEX-3-ENEKARBALDEHYDE IN PREVENTION AND TREATMENT OF COGNITIVE, NEURODEGETERATIVE OR NEURAL DISEASES
WO2014053110A3 (en) Peptides for the treatment and early diagnosis of alzheimer's disease and other tauopathies
BR112012008843A2 (en) Compound, pharmaceutical composition, use of the compound, e.g. mixture
MA39448A1 (en) (R) -pirlindole and its pharmaceutically acceptable salts for medical use
UA109359C2 (en) TREATMENT OF SKIN DISEASES AND STATES
WO2009134668A3 (en) 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators
MX350145B (en) Proteolytic extract from bromelain for the treatment of connective tissue disorders.